Talking Card for Asthma
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
Inclusion Criteria
- English-speaking primary caregiver
- Visit to study site clinic for asthma within 12 months of study recruitment
- Diagnosis of asthma (ICD-9 code 493.0) within 12 months of study recruitment
- ...
- English-speaking primary caregiver
- Visit to study site clinic for asthma within 12 months of study recruitment
- Diagnosis of asthma (ICD-9 code 493.0) within 12 months of study recruitment
- Child age 4 through 11 years old
- Enrollment in Medicaid insurance company within 12 months of study recruitment (original Kansas City site criterion, removed on revision)
Exclusion Criteria
- Visit to any primary care provider giving asthma action plan advice during the previous month
- Any major chronic illness including but not limited to non-skin cancer, cystic fibrosis, bronchiectasis, sickle cell anemia, endocrine disease, congenital heart disease, congestive heart failure, stroke, severe hypertension, insulin-dependent diabetes mellitus, renal failure, liver disorders, immunodeficiency states, significant neuro-developmental delay or behavioral disorders (excluding mild attention deficit hyperactivity disorder), or other conditions that would interfere with participation in the study
- Anticipated departure from study area before study period ends (3-month follow-up)
- ...
- Visit to any primary care provider giving asthma action plan advice during the previous month
- Any major chronic illness including but not limited to non-skin cancer, cystic fibrosis, bronchiectasis, sickle cell anemia, endocrine disease, congenital heart disease, congestive heart failure, stroke, severe hypertension, insulin-dependent diabetes mellitus, renal failure, liver disorders, immunodeficiency states, significant neuro-developmental delay or behavioral disorders (excluding mild attention deficit hyperactivity disorder), or other conditions that would interfere with participation in the study
- Anticipated departure from study area before study period ends (3-month follow-up)
- History of premature birth less than 33 weeks gestation or requirement of a significant level of respiratory care including mechanical ventilation as a neonate
Summary
- Conditions
- Asthma
- Type
- Interventional
- Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
Participation Requirements
- Age
- Between 4 years and 11 years
- Gender
- Both males and females
Inclusion Criteria
- English-speaking primary caregiver
- Visit to study site clinic for asthma within 12 months of study recruitment
- Diagnosis of asthma (ICD-9 code 493.0) within 12 months of study recruitment
- ...
- English-speaking primary caregiver
- Visit to study site clinic for asthma within 12 months of study recruitment
- Diagnosis of asthma (ICD-9 code 493.0) within 12 months of study recruitment
- Child age 4 through 11 years old
- Enrollment in Medicaid insurance company within 12 months of study recruitment (original Kansas City site criterion, removed on revision)
Exclusion Criteria
- Visit to any primary care provider giving asthma action plan advice during the previous month
- Any major chronic illness including but not limited to non-skin cancer, cystic fibrosis, bronchiectasis, sickle cell anemia, endocrine disease, congenital heart disease, congestive heart failure, stroke, severe hypertension, insulin-dependent diabetes mellitus, renal failure, liver disorders, immunodeficiency states, significant neuro-developmental delay or behavioral disorders (excluding mild attention deficit hyperactivity disorder), or other conditions that would interfere with participation in the study
- Anticipated departure from study area before study period ends (3-month follow-up)
- ...
- Visit to any primary care provider giving asthma action plan advice during the previous month
- Any major chronic illness including but not limited to non-skin cancer, cystic fibrosis, bronchiectasis, sickle cell anemia, endocrine disease, congenital heart disease, congestive heart failure, stroke, severe hypertension, insulin-dependent diabetes mellitus, renal failure, liver disorders, immunodeficiency states, significant neuro-developmental delay or behavioral disorders (excluding mild attention deficit hyperactivity disorder), or other conditions that would interfere with participation in the study
- Anticipated departure from study area before study period ends (3-month follow-up)
- History of premature birth less than 33 weeks gestation or requirement of a significant level of respiratory care including mechanical ventilation as a neonate
Tracking Information
- NCT #
- NCT02041013
- Collaborators
- University of South Florida
- Investigators
- Principal Investigator: John D Cowden, MD,MPH Children's Mercy Hospital Kansas City
- John D Cowden, MD,MPH Children's Mercy Hospital Kansas City
Get Well Soon